ğŸ§¬ GENE OF THE WEEK: SLCO1B1

30 million Americans take statins. 15-20% of them carry a variant that makes muscle pain and weakness far more likely.

SLCO1B1 encodes a transporter that moves statins from blood into the liver, where they work. If this transporter is impaired, statins accumulate in muscle tissue insteadâ€”causing myopathy.

Myopathy Risk by Genotype (rs4149056):

T/T â†’ 1x (Normal function)
T/C â†’ 4.5x increased risk (Intermediate function)
C/C â†’ 17x increased risk (Poor function)

The C allele is commonâ€”about 15-20% of people carry at least one copy.

Why This Matters:

Statin myopathy ranges from:
â†’ Mild muscle aches (most common)
â†’ Significant weakness
â†’ Rhabdomyolysis (rare but dangerous)

Many patients stop statins due to muscle symptomsâ€”even when they desperately need cardiovascular protection.

But the solution isn't "no statin"â€”it's the RIGHT statin at the RIGHT dose.

Affected Statins (High to Low Risk):

ğŸ”´ Simvastatin â€” Highest myopathy risk
ğŸŸ  Atorvastatin â€” Moderate risk
ğŸŸ¡ Rosuvastatin â€” Lower risk
ğŸŸ¢ Pravastatin â€” Lowest risk (doesn't use SLCO1B1)

CPIC Guidelines:

For C/C carriers:
â†’ Avoid simvastatin >20mg
â†’ Consider pravastatin or rosuvastatin
â†’ Start at reduced doses
â†’ Monitor CK levels

A $200 pharmacogenomic test could prevent years of "statin intolerance" and keep patients on life-saving therapy.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #SLCO1B1 #Statins #Pharmacogenomics #PrecisionMedicine #Bioscope
